Expression of soluble Fas in the cerebrospinal fluid of preterm infants with posthemorrhagic hydrocephalus and cystic white matter damage

Journal of Perinatal Medicine

Volumn 39, Issue 1, 2011, Pages 83-88

  Schmitz, Thomas ^a,b   Felderhoff Mueser, Ursula ^c   Sifringer, Marco ^a   Groenendaal, Floris ^d   Kampmann, Susanne ^a   Heep, Axel ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Cerebrospinal fluid; posthemorrhagic hydrocephalus; preterm infant; soluble Fas; white matter damage

Indexed keywords

FAS ANTIGEN;

ANASTOMOSIS; APOPTOSIS; ARTICLE; BRAIN CYST; BRAIN DAMAGE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; HYDROCEPHALUS; NEWBORN; PATHOGENESIS; PERIVENTRICULAR WHITE MATTER DAMAGE; PREMATURITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION;

ANTIGENS, CD95; APOPTOSIS; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; HUMANS; HYDROCEPHALUS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTRACRANIAL HEMORRHAGES; PROSPECTIVE STUDIES;

EID: 78651363198     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.125     Document Type: Article

References (35)

1. Behrman RE, Butler AS, editors. Institute of medicine com-mittee on understanding premature birth and assuring healthy outcomes board on health sciences outcomes: preterm birth: causes, consequences, and prevention. Washington DC: The National Academies Press; 2007.
2. Blaschke AJ, Weiner JA, Chun J. Programmed cell death is a universal feature of embryonic and postnatal neuroprolife-rative regions throughout the central nervous system. J Comp Neurol. 1998;396:39-50.
3. Boyd ZS, Kriatchko A, Yang J, Agarwal N, Wax MB, Patil RV. Interleukin-10 receptor signaling through STAT-3 regu-lates the apoptosis of retinal ganglion cells in response to stress. Invest Ophthalmol Vis Sci. 2003;44:5206-11.
4. Castejón O. Blood-brain barrier ultrastructural alterations in human congenital hydrocephalus and Arnold-Chiari malfor-mation. Folia Neuropathol. 2009;47:11-9.
5. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 1994;263:1759-62.
6. Debillon T, N'Guyen S, Muet A, Quere MP, Moussaly F Roze JC. Limitations of ultrasonography for diagnosing white matter damage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2003;88:F275-9.
7. Felderhoff-Mueser U, Buhrer C, Groneck P, Obladen M, Bart-mann P, Heep A. Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and non-hemorrhagic hydro-cephalus. Pediatr Res. 2003;54:659-64.
8. Felderhoff-Mueser U, Rutherford MA, Squier WV, Cox P, Maalouf EF, Counsell SJ, et al. Relationship between MR imaging and histopathologic findings of the brain in extreme-ly sick preterm infants. Am J Neuroradiol. 1999;20:1349-57.
9. Felderhoff-Mueser U, Sifringer M, Pesditschek S, Kuckuck H, Moysich A, Bittigau P, et al. Pathways leading to apoptotic neurodegeneration following trauma to the developing rat brain. Neurobiol Dis. 2002;11:231-45.
10. Folkerth RD. Neuropathologic substrate of cerebral palsy. J Child Neurol. 2005;20:940-9.
11. Folkerth RD. Periventricular leukomalacia: overview and recent findings. Ped Dev Pathol. 2006;9:3-13.
12. Folkerth RD, Keefe RJ, Haynes RL, Trachtenberg FL, Volpe JJ, Kinney HC. Interferon-gamma expression in periventri-cular leukomalacia in the human brain. Brain Pathol. 2004; 14:265-74.
13. Fukumizu M, Takashima S, Becker LE. Neonatal posthemor-rhagic hydrocephalus: neuropathologic and immunohistoche-mical studies. Pediatr Neurol. 1995;13:230-4.
14. Gordon N. Apoptosis (programmed cell death) and other rea-sons for elimination of neurons and axons. Brain Dev. 2005;17:73-7.
15. Hamrick SE, Miller SP, Leonard C, Glidden DV, Goldstein R, Ramaswamy V, et al. Trends in severe brain injury and neurodevelopmental outcome in premature newborn infants: the role of cystic periventricular leukomalacia. J Pediatr. 2004;145:593-9.
16. Hansen-Pupp I, Harling S, Berg AC, Cilio C, Hellstrom-Westas L, Ley D. Circulating interferon-gamma and white matter brain damage in preterm infants. Pediatr Res. 2005;58: 946-52.
17. Harris NG, Jones HC, Patel G. Ventricle shunting in young HTX rats with inherited congenital hydrocephalus: a quanti-tative histological study of cortical grey matter. Childs Nerv Syst. 1994;10:293-301.
18. Heep A, Stoffel-Wagner B, Bartmann P, Benseler S, Schaller C, Groneck P, et al. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res. 2004;56:768-74.
19. Kaukola T, Herva R, Perhomaa M, Pääkkö E, Kingsmore S, Vainionpää L, et al. Population cohort associating chorioam-nionitis, cord inflammatory cytokines and neurologic out-come in very preterm, extremely low birth weight infants. Pediatr Res. 2006;59:478-83.
20. Lenzlinger PM, Marx A, Trentz O, Kossmann T, Morganti-Kossmann MC. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans. J Neu-roimmunol. 2002;122:167-74.
21. Levene MI. Measurement of the growth of the lateral ventri-cles in preterm infants with real-time ultrasound. Arch Dis Child. 1981;56:900-4.
22. Munker R, Andreeff M. Induction of death (CD95/FAS), acti-vation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma. Cytokines Mol Ther. 1996;2:147-59.
23. Northington FJ, Ferriero DM, Flock DL, Martin LJ. Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci. 2001;21:1931-8.
24. Okano F, Yamada K. Canine interleukin-18 induces apoptosis and enhances Fas ligand mRNA expression in a canine car-cinoma cell line. Anticancer Res. 2000;20:3411-5.
25. PapoffG, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G. An N-terminal domain shared by Fas/Apo-1 (CD95) sol-uble variants prevents cell death in vitro. J Immunol. 1996;165:4622-30.
26. Roelants-van Rijn AM, Groenendaal F, Beek FJ, Eken P, van Haastert IC, de Vries LS. Parenchymal brain injury in the preterm infant: comparison of cranial ultrasound, MRI and neurodevelopmental outcome. Neuropediatrics. 2001;32:80-9.
27. Sabri F, Granath F, Hjalmarsson A, Aurelius E, Sköldenberg B. Modulation of sFas indicates apoptosis in human herpes simplex encephalitis. J Immunol. 2006;171:171-6.
28. Schmitz T, Heep A, Groenendaal F, Hüseman D, Kie S, Bart-mann P, et al. Interleukin-1beta, interleukin-18, and interfer-on-gamma expression in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus-markers of white matter damage? Pediatr Res. 2007;61:622-6.
29. Schneider E, Tonanny MB, Lisbonne M, Leite-de-Moraes M, Dy M. Pro-Th1 cytokines promote Fas-dependent apoptosis of immature peripheral basophils. J Immunol. 2004;172: 5262-8.
30. Towfighi A, Skolasky RL, St Hillaire C, Conant K, McArthur JC. CSF soluble Fas correlates with the severity of HIV-asso-ciated dementia. Neurology. 2004;62:654-6.
31. Vinukonda G, Csiszar A, Hu F, Dummula K, Pandey N, Zia M, et al. Neuroprotection in a rabbit model ofintraventricular haemorrhage by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha inhibition. Brain. 2010 (epub ahead of print).
32. Volpe JJ. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe JJ, editor. Neurology of the Newborn, 4th ed. Philadelphia: Saunders; 2001. pp. 428-93.
33. Volpe JJ. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics. 2003;112: 176-80.
34. Whitelaw A, Evans D, Carter M, Thoresen M, Wroblewska J, Mandera M, et al. Randomized clinical trial of prevention of hydrocephalus after intraventricular hemorrhage in preterm infants: brain-washing versus tapping fluid. Pediatrics. 2007; 119:e1071-8.
35. Whitelaw A, Saliba E, Fellman V, Mowinckel MC, Acolet D, Marlow N. Phase I study of intraventricular recombinant tis-sue plasminogen activator for treatment of posthaemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed. 1996;75: F20-6.